Singh Appu Kumar, Ekka Mary Krishna, Kaushik Abhishek, Pandya Vaibhav, Singh Ravi P, Banerjee Shrijita, Mittal Monica, Singh Vijay, Kumaran S
G. N. Ramachandran Protein Center, Institute of Microbial Technology (IMTECH), Council of Scientific and Industrial Research (CSIR) , Sector 39-A, Chandigarh, India 160036.
Biochemistry. 2017 Sep 19;56(37):5011-5025. doi: 10.1021/acs.biochem.7b00500. Epub 2017 Sep 1.
By classical competitive antagonism, a substrate and competitive inhibitor must bind mutually exclusively to the active site. The competitive inhibition of O-acetyl serine sulfhydrylase (OASS) by the C-terminus of serine acetyltransferase (SAT) presents a paradox, because the C-terminus of SAT binds to the active site of OASS with an affinity that is 4-6 log-fold (10-10) greater than that of the substrate. Therefore, we employed multiple approaches to understand how the substrate gains access to the OASS active site under physiological conditions. Single-molecule and ensemble approaches showed that the active site-bound high-affinity competitive inhibitor is actively dissociated by the substrate, which is not consistent with classical views of competitive antagonism. We employed fast-flow kinetic approaches to demonstrate that substrate-mediated dissociation of full length SAT-OASS (cysteine regulatory complex) follows a noncanonical "facilitated dissociation" mechanism. To understand the mechanism by which the substrate induces inhibitor dissociation, we resolved the crystal structures of enzyme·inhibitor·substrate ternary complexes. Crystal structures reveal a competitive allosteric binding mechanism in which the substrate intrudes into the inhibitor-bound active site and disengages the inhibitor before occupying the site vacated by the inhibitor. In summary, here we reveal a new type of competitive allosteric binding mechanism by which one of the competitive antagonists facilitates the dissociation of the other. Together, our results indicate that "competitive allostery" is the general feature of noncanonical "facilitated/accelerated dissociation" mechanisms. Further understanding of the mechanistic framework of "competitive allosteric" mechanism may allow us to design a new family of "competitive allosteric drugs/small molecules" that will have improved selectivity and specificity as compared to their competitive and allosteric counterparts.
根据经典的竞争性拮抗作用,底物和竞争性抑制剂必须相互排斥地结合到活性位点。丝氨酸乙酰转移酶(SAT)的C末端对O-乙酰丝氨酸巯基酶(OASS)的竞争性抑制呈现出一个悖论,因为SAT的C末端与OASS活性位点的结合亲和力比底物高4-6个对数级(10⁴-10⁶倍)。因此,我们采用了多种方法来理解在生理条件下底物如何进入OASS活性位点。单分子和整体方法表明,与活性位点结合的高亲和力竞争性抑制剂会被底物主动解离,这与经典的竞争性拮抗观点不一致。我们采用快速流动动力学方法来证明底物介导的全长SAT-OASS(半胱氨酸调节复合物)解离遵循一种非经典的“促进解离”机制。为了理解底物诱导抑制剂解离的机制,我们解析了酶·抑制剂·底物三元复合物的晶体结构。晶体结构揭示了一种竞争性变构结合机制,其中底物侵入与抑制剂结合的活性位点,在占据抑制剂腾出的位点之前使抑制剂脱离。总之,我们在此揭示了一种新型的竞争性变构结合机制,即一种竞争性拮抗剂促进另一种拮抗剂的解离。我们的结果共同表明,“竞争性变构”是非经典“促进/加速解离”机制的普遍特征。对“竞争性变构”机制的机械框架的进一步理解可能使我们能够设计出一类新的“竞争性变构药物/小分子”,与它们的竞争性和变构对应物相比,将具有更高的选择性和特异性。